KJ4-13364-38923
3 vaccinations
1 coded response
2 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 191 / PA
- Registered
- 2021-10-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-03
Dose 1 — Pfizer-BioNTech
-
2021-02-24
Dose 2 — Pfizer-BioNTech
-
2021-10-05
Dose 3 — Pfizer-BioNTech
-
2021-10-06
Registered in v-safe
-
2021-10-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Itching · Headache, Muscle or body aches, Fatigue or tiredness, Vomiting · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-26
Survey response — day 21, dose 3MedDRA: Muscle spasms — Feeling: GoodFree text: CrampingMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-03 | Pfizer-BioNTech | No |
| 2 | 2021-02-24 | Pfizer-BioNTech | No |
| 3 | 2021-10-05 | Pfizer-BioNTech | No |
Free text
Release 10 — day 21, dose 3
Symptoms: Cramping
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Muscle spasms | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release